The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
about
Metabolic dysfunction in Alzheimer's disease and related neurodegenerative disordersMolecular and biochemical trajectories from diabetes to Alzheimer's disease: A critical appraisalEvaluating the Association between Diabetes, Cognitive Decline and DementiaOn the Environmental Factors Affecting the Structural and Cytotoxic Properties of IAPP PeptidesMagnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer's modelA computational procedure for functional characterization of potential marker genes from molecular data: Alzheimer's as a case studyCaloric restriction improves diabetes-induced cognitive deficits by attenuating neurogranin-associated calcium signaling in high-fat diet-fed miceLinking type 2 diabetes and Alzheimer's disease.Altered gene expression profiles in the hippocampus and prefrontal cortex of type 2 diabetic ratsThe procognitive effects of leptin in the brain and their clinical implicationsNeuroprotective effects of treadmill exercise on BDNF and PI3-K/Akt signaling pathway in the cortex of transgenic mice model of Alzheimer's disease.Diabetes mellitus and Alzheimer's disease: shared pathology and treatment?Peptides from adipose tissue in mental disordersThe effect of Chinese Jinzhida recipe on the hippocampus in a rat model of diabetes-associated cognitive declineInsulin Activates Vagal Afferent Neurons Including those Innervating Pancreas via Insulin Cascade and Ca(2+) Influx: Its Dysfunction in IRS2-KO Mice with Hyperphagic Obesity.Insulin suppresses ghrelin-induced calcium signaling in neuropeptide Y neurons of the hypothalamic arcuate nucleusCross talk between O-GlcNAcylation and phosphorylation: roles in signaling, transcription, and chronic disease.Alzheimer's disease promotion by obesity: induced mechanisms-molecular links and perspectivesDiverse regulation of AKT and GSK-3β by O-GlcNAcylation in various types of cells.Neuroprotective and neurotrophic actions of glucagon-like peptide-1: an emerging opportunity to treat neurodegenerative and cerebrovascular disordersAmelioration of neurodegenerative changes in cellular and rat models of diabetes-related Alzheimer's disease by exendin-4Oxidative stress and expression of insulin signaling proteins in the brain of diabetic rats: Role of Nigella sativa oil and antidiabetic drugsInsulin receptor signaling mediates APP processing and β-amyloid accumulation without altering survival in a transgenic mouse model of Alzheimer's diseaseGLP-1 secretion by microglial cells and decreased CNS expression in obesity.Current understanding of HIV-associated neurocognitive disorders pathogenesis.An exploration of the potential mechanisms and translational potential of five medicinal plants for applications in Alzheimer's disease.Pathways to neurodegeneration: mechanistic insights from GWAS in Alzheimer's disease, Parkinson's disease, and related disordersAlzheimer's disease and type 2 diabetes: exploring the association to obesity and tyrosine hydroxylaseContributions of Nonhuman Primates to Research on Aging.The "aged garlic extract:" (AGE) and one of its active ingredients S-allyl-L-cysteine (SAC) as potential preventive and therapeutic agents for Alzheimer's disease (AD).Experimental induction of type 2 diabetes in aging-accelerated mice triggered Alzheimer-like pathology and memory deficitsThe Nuclear Receptor PPARgamma as a Therapeutic Target for Cerebrovascular and Brain Dysfunction in Alzheimer's DiseaseThe role of glucose transporters in brain disease: diabetes and Alzheimer’s Disease.Insulin as a Bridge between Type 2 Diabetes and Alzheimer Disease - How Anti-Diabetics Could be a Solution for Dementia.Common neurodegenerative pathways in obesity, diabetes, and Alzheimer's disease.Palmitic acid-induced neuron cell cycle G2/M arrest and endoplasmic reticular stress through protein palmitoylation in SH-SY5Y human neuroblastoma cells.Insulin promotes survival of amyloid-beta oligomers neuroblastoma damaged cells via caspase 9 inhibition and Hsp70 upregulation.Type 3 Diabetes: Cross Talk between Differentially Regulated Proteins of Type 2 Diabetes Mellitus and Alzheimer's Disease.Lipid Rafts: Linking Alzheimer's Amyloid-β Production, Aggregation, and Toxicity at Neuronal MembranesGlucagon-Like Peptide-1 (GLP-1) Treatment Ameliorates Cognitive Impairment by Attenuating Arc Expression in Type 2 Diabetic Rats.
P2860
Q24562763-271BAD7B-93B9-4977-B1E0-546D1744D957Q26783344-94C6B675-1828-429E-B004-17EE9637B892Q26801774-E338981E-01CE-41F7-B1B8-F889E54D2A8CQ27022467-3FDEA010-D094-47E6-B1D0-4FC6E4916355Q28543427-B31E467E-ED5A-48C9-BAAB-E087AB09B82EQ28741856-2BFD674E-7864-470A-AF1E-656CA768E3AFQ30772562-F3F57C13-0980-4487-98D5-8523CAA808A5Q33859703-DE2E1CA0-ED04-44A4-9E9A-81837D5583C8Q34173547-98E6590A-D2FA-4A06-9D9E-8CE396DB3374Q34389081-B058557D-4887-4001-AE08-EC5A2238CB96Q34563358-C98539AC-F523-42A2-A6FB-7885FA70F298Q34608998-24A10417-85EF-4B47-B72E-3DEC4284CD61Q34761266-AC7B1A15-7E8B-4A0E-BCC6-CFE8BE411F82Q34800307-4C3810D3-369D-45E4-87B1-A978A8E7FD4FQ34806702-E3C1C4BF-9804-4790-83DE-CC3C78033A25Q35645155-056A37F1-CF98-45FC-9634-36235589F538Q35804446-1B41DD87-7C10-44E9-9766-4EBC6F9A3C8AQ36026292-8CD2900B-8520-45AD-B774-992F6B981BE0Q36124002-CAA2B8D6-7103-4E00-919D-F247E53D4400Q36166654-E0937826-C781-47B8-895E-DF8490E57C22Q36253100-269351F7-06CF-4671-94B8-135FFBBB2DFAQ36372009-2CC7C1F9-5EC0-429B-96ED-13D1509AFB40Q36528274-3EBFF7AD-8823-41DD-8A4E-11E01C6958B1Q36539234-FDC0F1CB-72A2-476A-B05C-06716FBE2113Q36932005-2278B174-3F5C-47D8-8C41-AC1B36A876BCQ36987635-5F93F25E-2EDB-4DB7-8F02-8497CE461F1CQ37199221-B31BE4BE-1CC0-466C-8918-A9733B833F0BQ37212345-0731B876-69A8-461C-840C-E85FD313DFDFQ37265056-CD191F0A-6F04-4B23-B4F0-17BCBB975CE4Q37615989-03983C37-7345-4FB7-A0A8-9509FA5F371AQ37615991-4FE4E936-FAFC-49B7-9E5E-BB78F465CBCBQ37781280-78586896-2ED2-4AB6-9D78-F606C587FC99Q38064315-54E88A59-07AA-460A-95C6-D91E5EFC5DEEQ38234927-25C564DC-CF3F-433A-B1E1-95BD694A0698Q38828830-5737C0AD-83A8-431A-813A-71873ADB560FQ38939976-03E774DD-4615-4F07-974B-E7947A2D1554Q39701747-687F7251-0BDC-4B26-9BFB-0FF88FBBDEC1Q41087317-70419AD5-8911-43F7-893C-439EDC4E2EBBQ41604924-4D197156-5965-4F7C-8FE2-E449819D1D20Q41700809-3EC6CA90-1FE7-4718-B40A-A310D90BCB5D
P2860
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@ast
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@en
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@nl
type
label
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@ast
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@en
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@nl
prefLabel
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@ast
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@en
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@nl
P1476
The relationship between Alzheimer's disease and diabetes: Type 3 diabetes?
@en
P2093
Zina Kroner
P304
P577
2009-12-01T00:00:00Z